2017
DOI: 10.18632/oncotarget.14577
|View full text |Cite
|
Sign up to set email alerts
|

ABL2 suppresses FLT3-ITD-induced cell proliferation through negative regulation of AKT signaling

Abstract: The type III receptor tyrosine kinase FLT3 is one of the most commonly mutated oncogenes in acute myeloid leukemia (AML). Inhibition of mutated FLT3 in combination with chemotherapy has displayed promising results in clinical trials. However, one of the major obstacles in targeting FLT3 is the development of resistant disease due to secondary mutations in FLT3 that lead to relapse. FLT3 and its oncogenic mutants signal through associating proteins that activate downstream signaling. Thus, targeting proteins th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 34 publications
0
11
0
Order By: Relevance
“…In migrating cells, PEAK1 is associated with the actin cytoskeleton and focal adhesion and involved in cancer progression [32]. The non-receptor tyrosine-protein kinase ABL2 plays critical roles in inhibiting the proliferation, migration and invasion of cancer cells [33,34]. WWC1, which could restrict cell proliferation and increase cell apoptosis, is considered an important tumor suppressor gene [35,36].…”
Section: Discussionmentioning
confidence: 99%
“…In migrating cells, PEAK1 is associated with the actin cytoskeleton and focal adhesion and involved in cancer progression [32]. The non-receptor tyrosine-protein kinase ABL2 plays critical roles in inhibiting the proliferation, migration and invasion of cancer cells [33,34]. WWC1, which could restrict cell proliferation and increase cell apoptosis, is considered an important tumor suppressor gene [35,36].…”
Section: Discussionmentioning
confidence: 99%
“…ABL2 was annotated in the Ras signalling pathway. Some researchers have identified ABL2 as the target of many regulators to facilitate the proliferation process . Here, we proposed that hsa_circ_0006371 and hsa_circ_0004872 could sponge hsa‐miR‐424‐5p to up‐regulate ABL2 to be involved in the proliferation of HASMCs via the Ras signalling pathway.…”
Section: Discussionmentioning
confidence: 97%
“…One possible reason is that ABL2 affects not only Flt3 (fms-like tyrosine kinase 3 ligand) signaling but also AKT (also known as protein kinase B) signaling. 53 All these factors have been shown to be involved in the regulation of IL- 10 signaling. 54,55 In fact, T cells lacking ABL kinases exhibit reduced proliferation and production of IL-2 and IFN-c but display similar levels of IL-4 in response to T cell receptor stimulation.…”
Section: Discussionmentioning
confidence: 99%